ENTA
Enanta Pharmaceuticals Inc
12.20$
-3.4%
vs. previous close
Closing price · As of: Oct 6, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | -137.1% | – | – | – | – | |
| – | -4.0% | -3.3% | -4.3% | -19.4% | +85.6% | +35.3% | +0.6% | +6.1% | -2.6% | -3.3% | -2.0% | – | |
| – | +20.6% | -31.3% | -2.6% | +42.5% | -26.6% | -17.3% | -10.9% | -3.4% | -5.6% | -1.6% | -1.7% | – | |
| – | -122.3% | – | – | +240.0% | -98.8% | +1,767.3% | +1,430.9% | -83.3% | -153.5% | – | – | – | |
| – | -42.5% | +111.9% | +292.2% | +36.8% | -2.3% | -71.0% | -93.9% | +840.6% | -90.2% | -89.5% | -53.3% | – | |
| – | -210.8% | – | -110.8% | – | +261.3% | -106.3% | +506.2% | – | -2,160.0% | – | +17.3% | – | |
| – | +695.7% | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | -32.0% | – | – | – | – | – | – | – | |
| – | +31,856.5% | -12.7% | +3.6% | +8.5% | -30.9% | +38.1% | -6.7% | +29.5% | – | -111.4% | -24.0% | – | |
| – | – | – | -217.6% | – | +3,131.6% | -152.5% | – | – | – | -148.8% | – | – | |
| – | – | – | – | – | – | – | – | -145.8% | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 6, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.